Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure

BACKGROUND: Recent studies indicated that sodium glucose cotransporter (SGLT)2 inhibition increases levels of ketone bodies in the blood in patients with type 1 and 2 diabetes. Other studies suggested that in patients with chronic heart failure (CHF), increased myocardial oxygen demand can be provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Pietschner, R., Kolwelter, J., Bosch, A., Striepe, K., Jung, S., Kannenkeril, D., Ott, C., Schiffer, M., Achenbach, S., Schmieder, R. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579532/
https://www.ncbi.nlm.nih.gov/pubmed/34753480
http://dx.doi.org/10.1186/s12933-021-01410-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579532/
https://www.ncbi.nlm.nih.gov/pubmed/34753480
http://dx.doi.org/10.1186/s12933-021-01410-7

Ejemplares similares